ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Dispute At City of Hope Pits Center Against For-Profit Physician Group.

May 28, 2010

In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes

March 24, 1978

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

GM Sends STAR Information To Its Female Employees.

February 23, 2001

Cancer Researchers Ask Congress for Full Bypass Budge Funding

April 27, 1990

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002